195 related articles for article (PubMed ID: 23946869)
1. GT198 Splice Variants Display Dominant-Negative Activities and Are Induced by Inactivating Mutations.
Peng M; Yang Z; Zhang H; Jaafar L; Wang G; Liu M; Flores-Rozas H; Xu J; Mivechi NF; Ko L
Genes Cancer; 2013 Jan; 4(1-2):26-38. PubMed ID: 23946869
[TBL] [Abstract][Full Text] [Related]
2. Inactivating Mutations in GT198 in Familial and Early-Onset Breast and Ovarian Cancers.
Peng M; Bakker JL; Dicioccio RA; Gille JJ; Zhao H; Odunsi K; Sucheston L; Jaafar L; Mivechi NF; Waisfisz Q; Ko L
Genes Cancer; 2013 Jan; 4(1-2):15-25. PubMed ID: 23946868
[TBL] [Abstract][Full Text] [Related]
3. GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.
Yang Z; Peng M; Cheng L; Jones K; Maihle NJ; Mivechi NF; Ko L
Am J Pathol; 2016 May; 186(5):1340-50. PubMed ID: 27001628
[TBL] [Abstract][Full Text] [Related]
4.
Schubert S; Ripperger T; Rood M; Petkidis A; Hofmann W; Frye-Boukhriss H; Tauscher M; Auber B; Hille-Betz U; Illig T; Schlegelberger B; Steinemann D
Genes Cancer; 2017 Jan; 8(1-2):472-483. PubMed ID: 28435519
[No Abstract] [Full Text] [Related]
5. Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.
Peng M; Zhang H; Jaafar L; Risinger JI; Huang S; Mivechi NF; Ko L
J Biol Chem; 2013 Nov; 288(46):33387-97. PubMed ID: 24097974
[TBL] [Abstract][Full Text] [Related]
6. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis.
Zhang L; Wang Y; Rashid MH; Liu M; Angara K; Mivechi NF; Maihle NJ; Arbab AS; Ko L
Oncotarget; 2017 Aug; 8(31):51591-51607. PubMed ID: 28881671
[TBL] [Abstract][Full Text] [Related]
7. Functional pre- mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation.
Brooks YS; Wang G; Yang Z; Smith KK; Bieberich E; Ko L
J Biol Chem; 2009 Jul; 284(27):18033-46. PubMed ID: 19416963
[TBL] [Abstract][Full Text] [Related]
8. Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.
Achyut BR; Zhang H; Angara K; Mivechi NF; Arbab AS; Ko L
Cancer Lett; 2020 Apr; 476():57-66. PubMed ID: 32061755
[TBL] [Abstract][Full Text] [Related]
9. GT198 Is a Target of Oncology Drugs and Anticancer Herbs.
Pang J; Gao J; Zhang L; Mivechi NF; Ko L
Front Oral Health; 2021 Jun; 2():. PubMed ID: 34476412
[TBL] [Abstract][Full Text] [Related]
10. Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity.
Berge EO; Staalesen V; Straume AH; Lillehaug JR; Lønning PE
Biochim Biophys Acta; 2010 Mar; 1803(3):386-95. PubMed ID: 20080130
[TBL] [Abstract][Full Text] [Related]
11. Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation.
Yang Z; Sui Y; Xiong S; Liour SS; Phillips AC; Ko L
Nucleic Acids Res; 2007; 35(6):1919-32. PubMed ID: 17337438
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors.
Ko L; Cardona GR; Henrion-Caude A; Chin WW
Mol Cell Biol; 2002 Jan; 22(1):357-69. PubMed ID: 11739747
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of aberrant pre-mRNA splicing in humans.
Cogan JD; Prince MA; Lekhakula S; Bundey S; Futrakul A; McCarthy EM; Phillips JA
Hum Mol Genet; 1997 Jun; 6(6):909-12. PubMed ID: 9175738
[TBL] [Abstract][Full Text] [Related]
14. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer.
Thompson TE; Rogan PK; Risinger JI; Taylor JA
Cancer Res; 2002 Jun; 62(11):3251-6. PubMed ID: 12036941
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific transcription start sites and alternative splicing of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor gene: a new PTH/PTHrP receptor splice variant that lacks the signal peptide.
Joun H; Lanske B; Karperien M; Qian F; Defize L; Abou-Samra A
Endocrinology; 1997 Apr; 138(4):1742-9. PubMed ID: 9075739
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling.
Wang L; Oh DY; Bogerd J; Choi HS; Ahn RS; Seong JY; Kwon HB
Endocrinology; 2001 Sep; 142(9):4015-25. PubMed ID: 11517181
[TBL] [Abstract][Full Text] [Related]
17. The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells.
Sevcik J; Falk M; Kleiblova P; Lhota F; Stefancikova L; Janatova M; Weiterova L; Lukasova E; Kozubek S; Pohlreich P; Kleibl Z
Cell Signal; 2012 May; 24(5):1023-30. PubMed ID: 22245140
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal leiomyosarcoma in a female patient with a germline splicing variant RAD51D c.904-2A > T: a case report.
Futagawa M; Yamamoto H; Kochi M; Urakawa Y; Sogawa R; Kato F; Okazawa-Sakai M; Ennishi D; Shinozaki K; Inoue H; Yanai H; Hirasawa A
Hered Cancer Clin Pract; 2021 Nov; 19(1):48. PubMed ID: 34838098
[TBL] [Abstract][Full Text] [Related]
19. Alterations of pre-mRNA splicing in cancer.
Kalnina Z; Zayakin P; Silina K; Linē A
Genes Chromosomes Cancer; 2005 Apr; 42(4):342-57. PubMed ID: 15648050
[TBL] [Abstract][Full Text] [Related]
20. Functionally diverse complement of large conductance calcium- and voltage-activated potassium channel (BK) alpha-subunits generated from a single site of splicing.
Chen L; Tian L; MacDonald SH; McClafferty H; Hammond MS; Huibant JM; Ruth P; Knaus HG; Shipston MJ
J Biol Chem; 2005 Sep; 280(39):33599-609. PubMed ID: 16081418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
